Healthleap Raises $38M for AI That Flags At-Risk Hospital Patients

What happened

Founded in South Africa in 2022 by siblings Jemima and Josiah Meyer, the startup began as a clinical nutrition tool for dietitians before pivoting to a more general platform. It plugs into a hospital's electronic health record system, uses language models to pull signals from clinicians' written notes — poor appetite, recent weight loss, trouble swallowing — and feeds them into risk models alongside labs and vitals.

The platform is currently deployed in more than 50 hospitals, up from three partners a year ago, and screens patients for malnutrition, delirium, aspiration pneumonia, pressure ulcers and congestive-heart-failure readmission risk. Customers include Penn Medicine, Cedars-Sinai, Intermountain, Houston Methodist and Emory Healthcare; revenue has grown more than 10x over the past year.

The company sells three-year contracts priced by licensed bed count, with outcome-based pricing — it says every customer has seen at least 5x hard ROI. At the Hospital of the University of Pennsylvania, its malnutrition program is said to have delivered $23.8 million in annualized financial impact.

Key facts

1. Round: : $38M total — $8M seed (Sequoia, First Round) + $30M Series A (Hummingbird); valuation undisclosed
2. Founders: : siblings Jemima and Josiah Meyer, founded 2022 in South Africa; started as a dietitian nutrition tool
3. Traction: : 50+ hospitals (from 3 a year ago), 10x+ revenue growth; customers include Penn Medicine, Cedars-Sinai, Emory
4. Model: : doesn't diagnose — only flags items for additional review; outcome-based pricing, claims 5x+ hard ROI per customer
5. Next: : expand to 40+ major conditions and into outpatient and home care